comparemela.com

Page 7 - Christoph Hock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Neurimmune enters into a collaboration and license agreement with AstraZeneca to develop and commercialize NI006

/PRNewswire/ Neurimmune AG today announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca s Rare.

Neurimmune enters into a collaboration and license agreement with AstraZeneca to develop and commercialize NI006

/PRNewswire/ Neurimmune AG today announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca s Rare.

Neurimmune enters into a collaboration and license agreement with AstraZeneca to develop and commercialize NI006

Neurimmune enters into a collaboration and license agreement with AstraZeneca to develop and commercialize NI006 Zurich, Switzerland, January 7, 2022 – Neurimmune AG today announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s Rare Dise.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.